We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Canadian Agency Rules That Food Ingredient That Induces Feelings Of Fullness Is Non-Novel

November 12, 2010: 09:32 AM EST

Health Canada has confirmed in a letter of non-objection that Kemin Health’s Slendesta food ingredient is not considered a novel food and may be marketed as such for use in conventional foods and beverages without a pre-market notification process. Slendesta has achieved the same status in Europe; in the U.S. the FDA ruled it was GRAS (generally recognized as safe) for use in foods and beverages. The active component in Slendesta, Proteinase Inhibitor II (PI2), is derived from U.S.-grown white potatoes. According to the company, the compound enhances the body’s natural release of cholecystokinin (CCK), a signaling peptide that travels through the bloodstream and helps induce feelings of fullness and satisfaction, thus helping people control hunger and perhaps make dieting easier.

"Slendesta Now has non-Novel Food Status in Canada", News release, Kemin Industries, Inc., November 12, 2010, © Kemin Industries, Inc.
Vitality & Better Living
North America
Companies, Organizations
Legal, Legislation, Regulation, Policy
Market News
Press Release
Products & Brands
Developed by Yuri Ingultsov Software Lab.